Upregulation of acetylcholine synthesis by bone morphogenetic protein 9 in a murine septal cell line

J Physiol Paris. 2002 Jan-Mar;96(1-2):53-9. doi: 10.1016/s0928-4257(01)00080-8.

Abstract

Previous studies showed that bone morphogenetic protein 9 (BMP-9) induces the expression of choline acetyltransferase and the vesicular acetylcholine (ACh) transporter, and upregulates ACh synthesis in cultured primary neurons from embryonic mouse septum [I. López-Coviella, B. Berse, R. Krauss, R.S. Thies, J.K. Blusztajn, Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science 289 (2000) 313-316]. In the present studies we investigated the effects of BMP-9 on ACh synthesis in the cholinergic mouse SN56T17 septal cell line. BMP-9 increased ACh synthesis in these cells up to 2.5-fold in a time- and dose-dependent, saturable manner. The maximal effect of BMP-9 was observed after a 3-day treatment and the median effective concentration of BMP-9 was 0.5 ng/ml. These data show that SN56T17 cells are a useful model for studies of the effects of BMPs on the cholinergic phenotype.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcholine / biosynthesis*
  • Animals
  • Bone Morphogenetic Proteins / administration & dosage
  • Bone Morphogenetic Proteins / pharmacology*
  • Cell Line
  • Dose-Response Relationship, Drug
  • Embryo, Mammalian
  • Growth Differentiation Factor 2
  • Mice
  • Osmolar Concentration
  • Septum Pellucidum / cytology
  • Septum Pellucidum / metabolism*
  • Time Factors
  • Up-Regulation

Substances

  • Bone Morphogenetic Proteins
  • Gdf2 protein, mouse
  • Growth Differentiation Factor 2
  • Acetylcholine